RCT | Efficacy and safety of topical nitric oxide releasing Berdazimer gel in patients with molluscum contagiosum.

Efficacy and Safety of Topical Nitric Oxide−Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial – JAMA Dermatology

Commentary on Twitter

This randomized, vehicle-controlled trial of molluscum contagiosum patients found the efficacy and safety of a once-daily application of berdazimer gel, 10.3% an experimental topical, nitric oxide-releasing medication. https://t.co/zKuA29BTPS

— JAMA Dermatology (@JAMADerm) July 13, 2022